RecruitingPHASE1, PHASE2NCT03603405

HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Studying Anaplastic astrocytoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Methodist Hospital Research Institute
Principal Investigator
David S. Baskin, MD
Houston Methodist Neurological Institute
Intervention
ADV/HSV-tk (gene therapy)(drug)
Enrollment
62 enrolled
Eligibility
18 years · All sexes
Timeline
2018 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03603405 on ClinicalTrials.gov

Other trials for Anaplastic astrocytoma

Additional recruiting or active studies for the same condition.

See all trials for Anaplastic astrocytoma →

← Back to all trials